Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will ...

AstraZeneca will market the therapy as Lokelma, while Sun Pharma will promote and distribute it as Gimliand. AstraZeneca will ...

President Donald Trump keeps downplaying America’s affordability crisis, and he continues to falsely claim that inflation and ...

Propellants in asthma inhalers produce greenhouse gas emissions equivalent to driving 200 miles, yet most healthcare systems ...

Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...

Pharmaceutical company AstraZeneca and the Taizhou National Medical High-tech Development Zone in Jiangsu province inked an ...

Mikael Dolsten, Pfizer's former research and development ​chief, has withdrawn his candidacy for ‌Novo Nordisk's board, ...

The White House just announced that AstraZeneca and Pfizer will start charging foreign health systems the same prices for all newly launched treatments as they charge here in America. Bristol-Meyers ...

The White House just announced that AstraZeneca and Pfizer will start charging foreign health systems the same prices for all newly launched treatments as they charge here in America.

The latest health news includes concerns over radioactive contamination in Indonesia, generic Ozempic's anticipated launch in Canada, regulatory impacts on Edenred in Brazil, AstraZeneca's market ...

(Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, ...